Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: MENARINI INTERNATIONAL O.L.S.A., 1, Avenue de la Gare, L-1611, Luxembourg
Keral 25 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablet. Keral 25 mg: white, round, scored film-coated tablet. The tablets can be divided into equal doses. |
Each tablet contains: dexketoprofen 25 mg as dexketoprofen trometamol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dexketoprofen |
Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action. |
| List of Excipients |
|---|
|
Tablet core: Maize starch Film-coating: Dry laquer composed of: Hypromellose |
Tablets are provided in blister packs (PVC-aluminium blister or Aclar-aluminium blister).
Keral 25 mg tablets – 4, 10, 20, 30, 50 or 500 film-coated tablets/pack
Not all pack sizes may be marketed.
MENARINI INTERNATIONAL O.L.S.A., 1, Avenue de la Gare, L-1611, Luxembourg
PL 16239/0007
Date of first authorisation: 14 January 1998
Date of latest renewal: 25 April 2006
| Drug | Countries | |
|---|---|---|
| KERAL | Ireland, Malta, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
